Drug Profile
NSAID/tranexamic acid - Arstat
Alternative Names: EnhantaLatest Information Update: 20 Jul 2016
Price :
$50
*
At a glance
- Originator ARSTAT
- Class Cyclohexanecarboxylic acids; Nonsteroidal anti-inflammatories; Small molecules
- Mechanism of Action Cyclooxygenase inhibitors; Plasminogen activator inhibitors
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
- New Molecular Entity No
- Available For Licensing Yes
Highest Development Phases
- Phase Unknown Dysmenorrhoea; Menorrhagia
Most Recent Events
- 20 Jul 2016 NSAID/tranexamic acid - Arstat is available for licensing - http://arstatinc.com/ARSTAT_Combination.pdf
- 20 Jul 2016 Investigation in Dysmenorrhoea in USA (PO)
- 20 Jul 2016 Investigation in Menorrhagia in USA (PO)